Payoneer Global Inc Stock News

Payoneer Global is undervalued due to fears over short-term interest rate headwinds, despite strong long-term growth targets and conservative guidance. The global payments company reported robust Q4 results, with revenue up 16.7% YoY, but the stock has fallen 30% due to guidance concerns. Payoneer aims for 20% revenue growth and a 25% EBITDA margin, with a $500 million cash balance and a low EV...

NEW YORK--(BUSINESS WIRE)--Payoneer Global Inc. (NASDAQ: PAYO) today announced that senior management will participate in a fireside chat at the Wolfe Research FinTech Forum.

Payoneer Global Inc. (NASDAQ:PAYO ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Caius Slater - Director, Investor Relations John Caplan - Chief Executive Officer Bea Ordonez - Chief Financial Officer Conference Call Participants Sanjay Sakhrani - KBW Nate Svensson - Deutsche Bank Will Nance - Goldman Sachs Cris Kennedy - William Blair Spencer James - Jeffe...

NEW YORK--(BUSINESS WIRE)--Payoneer Global Inc. (NASDAQ: PAYO) today reported financial results for its fourth quarter and full year ended December 31, 2024.

NEW YORK--(BUSINESS WIRE)--Payoneer (NASDAQ: PAYO) today announced that its Board of Directors (“the Board”) has appointed Barak Eilam to the Board as a Class I director.

NEW YORK--(BUSINESS WIRE)--Payoneer (NASDAQ: PAYO) will report its Fourth Quarter and Full Year 2024 financial results on Thursday, February 27, 2025, before the market opens.

NEW YORK--(BUSINESS WIRE)--Payoneer (NASDAQ: PAYO), the financial technology company empowering the world's small and medium-sized businesses (SMBs) to transact, do business, and grow globally, today announced that it has received the regulatory approvals in China required to complete its previously announced acquisition of a licensed China-based payment service provider. The transaction is exp...

The 'Undercovered' Dozen series highlights lesser-covered stocks, offering fresh investment ideas and sparking community discussions on their potential. Ubiquiti Inc. shows promise with operational improvements, Ready Capital Corporation faces liquidity risks, and TORM plc is crucial despite energy sector volatility. Esperion Therapeutics' breakout and Cardiff Oncology's promising trial data pr...